2013影响创新

获奖者

 

AAMDSThe Aplastic Anemia & MDS International Foundation received the hematology Innovation Impact Award for the MDS Clinical Research Consortium.  Established in July 2012, the MDS Clinical Research Consortium is an unprecedented collaboration of the six largest MDS centers in the U.S. and is designed to undertake unique studies and trials to advance treatments and improve outcomes for patients with 骨髓增生异常综合征 (MDS)。 The Consortium enlists multiple MDS clinical research centers and fills a major gap in MDS-related clinical research in the 美国 by providing a new “critical mass” of patients and patient data to support the evaluation of promising new compounds, epidemiological studies, and translational studies leading to new classifications, treatments, and procedures. In this collaborative environment, enhanced by expanded access to patient data, tissue samples, and the use of a standardized patient work-up, research leading to potentially beneficial outcomes for patients is accelerated.

“Even from the earliest stages of development , we believed that the MDS Clinical Research Consortium was an innovative , game changing project that was perfectly aligned with our strategic plan.  It is exciting –and humbling—to see that others are seeing it in the same way. We are very pleased and honored to be selected for this new and prestigious award.  We deeply appreciate the support of the Edward P. Evans  Foundation and our six Consortium partners who have made this program possible and for the hope it brings to patients and families for new treatments and a cure for MDS. “–John Huber, Executive Director, AA&MDSIF

www.aamds.org

 

Lung cancer alliance肺癌联盟(LCA)受到的冲击创新奖肿瘤学“的国家框架,卓越的肺癌筛查和持续照顾”的倡议。这首先它的种类进行肺癌筛查的国家框架是一种合作的方式通过肺癌的现状和突破产生积极的影响在15%的存活率几乎没有哪四十年来发生了变化。从2012年与肺癌各领域的LCA召开的思想领袖,制定了“国家框架”这已经超过收养被100个医疗机构全国并赞同专业社团众多。从获奖的资金将有助于扶持力度,通过教育一个屡获殊荣的公众宣传活动有风险,鼓励更多的医疗设施采用国家框架和实施最佳做法和准则,以及改善和扩大肺癌筛查。

“我们非常荣幸和高兴能获得ESTA殊荣。 Celgene公司和我们感谢评奖委员会对精神错乱的我国优秀的框架的肺癌筛查和持续照顾救生影响。这意味着这么多的员工,卓越的100个多名筛选中心下面的框架和最重要的是,对于那些确诊的个体或有患肺癌的风险。这是一个值得骄傲的时刻,更新我们通过帮助社区,推进癌症筛查和加速research. - 劳瑞肺芬顿刘汉铨,总裁兼首席执行官,肺癌联盟拯救生命的承诺

www.lungcanceralliance.org

 

奖励计划仅适用于美国居民